Production (Stage)
Lifevantage Corporation
LFVN
$12.66
-$0.54-4.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 222.35M | 212.15M | 196.01M | 200.16M | 205.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 222.35M | 212.15M | 196.01M | 200.16M | 205.45M |
| Cost of Revenue | 43.82M | 42.88M | 40.75M | 41.44M | 42.49M |
| Gross Profit | 178.53M | 169.27M | 155.26M | 158.72M | 162.97M |
| SG&A Expenses | 165.57M | 158.43M | 149.11M | 154.39M | 159.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 209.39M | 201.31M | 189.86M | 195.83M | 201.83M |
| Operating Income | 12.96M | 10.84M | 6.15M | 4.33M | 3.63M |
| Income Before Tax | 12.56M | 10.30M | 6.10M | 4.35M | 4.19M |
| Income Tax Expenses | 3.41M | 2.96M | 1.96M | 1.41M | 596.00K |
| Earnings from Continuing Operations | 9.15 | 7.34 | 4.13 | 2.94 | 3.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.15M | 7.34M | 4.13M | 2.94M | 3.60M |
| EBIT | 12.96M | 10.84M | 6.15M | 4.33M | 3.63M |
| EBITDA | 16.17M | 14.15M | 9.61M | 7.91M | 7.30M |
| EPS Basic | 0.75 | 0.60 | 0.34 | 0.24 | 0.29 |
| Normalized Basic EPS | 0.64 | 0.53 | 0.31 | 0.22 | 0.19 |
| EPS Diluted | 0.69 | 0.56 | 0.32 | 0.23 | 0.27 |
| Normalized Diluted EPS | 0.60 | 0.50 | 0.29 | 0.21 | 0.18 |
| Average Basic Shares Outstanding | 48.98M | 49.05M | 49.45M | 49.83M | 50.19M |
| Average Diluted Shares Outstanding | 52.17M | 51.85M | 51.29M | 51.57M | 51.69M |
| Dividend Per Share | 0.16 | 0.16 | 0.15 | 0.15 | 0.14 |
| Payout Ratio | 21.94% | 26.61% | 46.11% | 236.30% | 191.27% |